When the MSI CRC subgroups were compared to each other, only minor differences were found in neutral N-glycan profiles, whereas a clear association between tumor stage and BRAF mutation status was observed in the acidic N-glycan profiles. The gene discussed is BRAF; the disease is neoplasm.